Immunome (IMNM) Change in Cash (2019 - 2026)

Immunome has reported Change in Cash for 8 years, with the latest figure at -$70.8 million in Q1 2026.

• For the quarter ending Q1 2026, Change in Cash fell 161.95% year-over-year to -$70.8 million; the trailing twelve-month figure through Mar 2026 stood at $325.2 million (up 2785.3% YoY), and the FY2025 full-year result was $510.2 million, up 1042.19% from the prior year.
• Change in Cash for Q1 2026 stood at -$70.8 million, down from $380.8 million in the prior quarter.
• The five-year high for Change in Cash was $380.8 million in Q4 2025, with the low at -$113.6 million in Q2 2025.
• Historically, Change in Cash has averaged $31.4 million across 5 years, with a median of -$6.4 million in 2022.
• Annual changes were most pronounced in 2024 — Change in Cash slumped 1637.53% — and 2025, when it soared 3217.32%.
• Immunome's Change in Cash stood at -$6.8 million in 2022, then soared by 218.99% to $8.0 million in 2023, then tumbled by 251.99% to -$12.2 million in 2024, then soared by 3217.32% to $380.8 million in 2025, then sank by 118.59% to -$70.8 million in 2026.
• The last three Change in Cash figures came in at -$70.8 million (Q1 2026), $380.8 million (Q4 2025), and $128.8 million (Q3 2025), per Business Quant data.